If this happens, other drugs might be tried The types of drugs used for stage iv breast cancer depend on the hormone receptor status, the her2 status of the cancer, and sometimes gene mutations that might be found While this standard remains foundational. The treatment landscape in hr+/her2− metastatic breast cancer (mbc) is continuously evolving, with evidence on new agents and combinations published almost every year While the first line treatment has remained a combination of dual her2 blockade with taxane chemotherapy, we now have several exciting options in the second line and beyond Patients were randomly assigned in a 1:1:1 ratio to receive trastuzumab deruxtecan plus pertuzumab
Or a taxane, trastuzumab, and pertuzumab.
OPEN
